During the year ended December 31, 2025, Curaleaf invested $63.4 million in capital expenditures, focused on facility upgrades, automation and selective retail expansion in strategic markets. The ...

Q4 2025 Earnings Call February 27, 2026 8:00 AM ESTCompany ParticipantsTrip TaylorJohn Treace - Founder, Chairman ...

Operator: Good day, everyone, and thank you for joining us for the Gray Media, Inc. Q4 2025 Earnings Release Call.

Following a record loss in 2025, Puma is aiming for a return to the top tier. A new strategy focuses on sporting heritage, training and structural changes.

Increased 2025 Revenue by 14% Year-over-Year to $748.3 Million, Driven by Global Growth in Social, CTV Measurement, and ...

Q4 2025 Earnings Call February 26, 2026 10:00 AM ESTCompany ParticipantsSherry Lauderback - Vice President of Investor ...

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of ...

Pfizer agreement announced in January 2026 for non-exclusive license to utilize Matrix-M® in two infectious disease areas Multiple Material Transfer Agreements signed ...

Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the fourth quarter and year ended December 31, 2025.

Pursuit Reports Full Year and Fourth Quarter 2025 Results, Provides 2026 Guidance and Introduces Long-Term Financial Targets ...

The U.S. government shutdown led to reduced military business growth in Q4 and created residual effects anticipated to affect performance into 2026. Management stated supply chain delays in part ...